B. Riley initiated coverage of Foghorn Therapeutics (FHTX) with a Buy rating and $10 price target. The firm says its investment thesis centers on the company’s strategy to inactivate or degrade ...

Foghorn Therapeutics (FHTX) has received a new Buy rating, initiated by B.Riley Financial analyst, Kalpit Patel. Kalpit Patel’s rating is based on Foghorn Therapeutics’ innovative approach to ...

all without needing to install a separate motion sensor. Even better, your Ambient Sensing-enabled Hue lights would be able to trigger security alerts when they detect motion where there shouldn ...

Anti-CD70 UCAR-T cells were then generated by knocking out TRAC, B2M, and HLA-DRA. To address the limitations of UCAR-T therapy, we developed an 'all-in-one' self-activated and protective (SAP) module ...

There were delays on the M4 this morning following a collision. The incident at J47 in Swansea caused delays on the eastbound side of the carriageway. According to traffic monitoring system Inrix ...